Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Phase II study of efficacy of bevacizumab and erlotinib in inoperable previously untreated hapatocellular carcinoma (HCC)

Govindarajan R, Siegel E, Makhoul I, Williamson S. Phase II study of efficacy of bevacizumab and erlotinib in inoperable previously untreated hapatocellular carcinoma (HCC). Annual Gastrointestinal Cancers Symposium. 2009.


collapse authors with profiles